A B S T R A C T Products secreted by Streptococcus intermedius were studied for their effects on the immune response. Three different preparations of crude extracellular products from S. intermedius (CEP-Si) were found to have powerful suppressor activity in vitro as shown by inhibition of human lymphocyte proliferation (uptake of [3H]thymidine) and protein synthesis in response to a wide variety of stimulants, including mitogens and antigens, and suppression of plaque formation by human cells in response to sheep erythrocytes. CEP-Si was noncytotoxic, because cells incubated with high concentrations of CEP-Si and subsequently washed were viable and recovered their ability to respond to mitogens, and because leukocyte migration was not inhibited by CEP-Si, nor was the release of leukocyte migration inhibitory factor from sensitized lymphocytes. The possibility of antigen or mitogen competition was excluded. The effects of CEP-Si in vitro were time dependent and did not require the presence of monocytes. Cells pretreated with CEP-Si and then washed suppressed plaque formation by fresh autologous cells in highly stimulated cultures. CEP-Si injected into C57BL/6 mice also strongly suppressed their immune response to sheep erythrocytes, and the in vivo suppression was correlated with the effects of CEP-Si in vitro.
INTRODUCTION
It has been reported that hosts heavily infected with microorganisms are immunologically unresponsive This manuscript is publication 265 from the Department of Basic and Clinical Immunology and Microbiology, Medical University of South Carolina.
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( [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . This state of immunosuppression has been attributed to the generation of suppressor monocytes (4, (8) (9) (10) or suppressor T lymphocytes (1, 2, 6, 9) , and it has been suggested (9) that such suppressor cells are generated as a result of hyperstimulation and deregulation of immunosuppressor control mechanisms in the presence of large amounts of antigen. It is also conceivable, however, as noted by Schwab (11) , that the infecting microorganisms could produce substances (not necessarily toxins) directly able to suppress the host's immune response in order to survive in an adverse environment. Previous studies have shown suppressive effects ofnoncytotoxic cellular extracts from group A streptococci and of streptococcal lipoteichoic acid on immune responses of mice in vivo (12) (13) (14) (15) ; however, in vitro suppression by these substances either was not studied or when studied was not observed (14) , although noncytotoxic immunosuppression in vitro and in vivo by enzymes secreted by bacteria, such as ribonuclease (16) , L-glutamine (17) , and asparaginase (18) , has been reported.
The study of substances with immunosuppressive activity that may be released by bacteria is of obvious importance in regard to the control of infection, particularly if the in vitro activity corresponds to a similar phenomenon in vivo and vice versa. Indeed, demonstration of in vitro activity is important for extrapolation of results from experimental animals to human beings. In addition, studies of the mechanism of action of any noncytotoxic immunosuppressor are of interest. Therefore, we have studied the in vitro and in vivo effects and mechanism(s) of action of the suppressor activity present in crude extracellular products secreted by Streptococcus intermedius (CEP-Si),' which some of us have previously shown ' Abbreviations used in this paper: CEP-Si, crude extracellular products secreted by Streptococcus intermedius; Chagrin Falls, Ohio) was used as tissue culture medium, supplemented with 20% fresh, heat-inactivated human AB serum and antibiotics (100 U/ml penicillin, 100 Ag/ml streptomycin).
The medium was buffered with Tris-HCl. PHA (Gibco), concanavalin A (ConA, Sigma Chemical Co., St. Louis, Mo.), pokeweed mitogen (PWM), and purified protein derivative of tuberculin (PPD, Serum Statenstinstitut, Copenhagen, Dennark) were used as stimulants at final concentrations of 1/40, 8 ,g/ml, 1/100, and 10 ug/ml, respectively. In the case ofthymocytes, PHA was the only stimulant used. In some instances, the cells were preincubated in medium 24-96 h before stimulation by PHA. Cultures of 3 x 105 mononuclear cells/ml in 1 ml of tissue culture medium were performed in triplicate or quadruplicate. In some instances a bidirectional mixed lymphocyte culture (MLC) was performed with 1.5 x 105 mononuclear cells from each of two HLA-incompatible human donors. CEP-Si was added at dilutions ranging from 1/200 to 1/25,600 (i.e., equivalent to 32-0.25 ,ug of protein detected in CEP-Si) at various times of culture, either before, after, or at the same time as the stimulant. In some experiments, CEP-Si was added daily to some cultures. In some experiments CEP-Si was washed out of the cell suspensions after incubation, and in others CEP-Si-treated cells stimulated with PHA or PPD and subsequently washed were added to fresh cells (not treated with CEP-Si).
CEP-Si was also tested for its effects on suspensions of purified T cells. These cell suspensions were prepared as follows. Mononuclear Fauci and Pratt (28, 29) . Peripheral blood mononuclear cells from human volunteers were separated on Ficoll gradients as described above and adjusted to 2.5 x 106 cells/ml in RPMI 1640 which contained 100 U/ml penicillin and 100 ,ug/ml streptomycin, buffered with sodium bicarbonate, and supplemented with 10% human heat-inactivated AB serum previously exhaustively absorbed with SRBC in the cold. 1-ml samples (instead of 2-ml samples as in the original method) of the suspension were incubated in Falcon tubes (Cat. 2051, Falcon Labware) on a rocker platform (10 cycles/min) in a humidified atmosphere of 5% CO2. All the cultures were costimulated with 106 mitomycin-treated mononuclear cells from an HLA-incompatible donor (MLC), the SRBC (5 x 106 cells/ml) were added to some cultures.
The effects of CEP-Si were tested in these cultures either by addition of different amounts directly to the cultures containing SRBC or by addition of different concentrations of autologous cells which had been treated with CEP-Si and then washed. In the latter event, the cells were either incubated with CEP-Si under the conditions described above with SRBC or in some instances stimulated with PPD as described above and subsequently washed. In both cases these cells were added to fresh cells which were either unstimulated or stimulated with SRBC. All the cultures were fed with 5 mM L-glutamine daily and incubated for 7 In vivo assays. C57BL/6 mice 6-wk-old were used. All mice were immunized by intraperitoneal injection of SRBC diluted 1/20 (vol/vol) in 0.3 ml buffered saline solution. Primary immunization was assayed 5 d later. The mice were killed, their spleens were removed and gently teased, and the separated mononuclear cells were assayed for formation of hemolytic plaques as described above. CEP-Si was injected intraperitoneally either on the day ofimmunization (day 0), 15, 6, 4, or 2 d before (days -15, -6, -4, -2), or 2 or 4 d afterward (days +2, +4) at a constant dose of 5,000 U of PPD biological activity (as defined below). On day -2, CEP-Si from the three different batches was injected at various doses, measured in units of PHA or PPD biological activity (see below). Groups of three animals each were usually used for each treatment, and experiments were repeated five times. Controls consisted of animals not injected with CEP-Si and animals not receiving any treatment. Some mice were first given 400 or 250 rads total-body irradiation. Those receiving 400 rads were immunized 10 d after irradiation and those receiving 250 rads 3 d after immunization. CEP-Si (5,000 U) was given to these mice only on day -2. In two sets of experiments, mice were injected weekly with 5,000 U of CEP-Si for 5wk, and 3 mo after discontinuation of the treatment they were immunized with SRBC.
Preliminary assay of purification of CEP-Si. Isoelectric focusing was conducted by the method of Amaud and Coryssel (31) in thin-layer polyacrylamide gels with a pH gradient of 3.5-8. The samples of CEP-Si were applied by means of0.5 x 1.0-cm filter paper pads. After electrofocusing, the gels were cut in sections, after determination of the pH. These sections were subsequently removed, incubated in phosphate-buffered saline, and the substances were eluted from the gel by repeated freezing and thawing.
The ampholytes were removed by means of gel filtration on Sephadex G-75 (Pharmacia Fine Chemicals, Inc.). As The effects of CEP-Si varied somewhat from batch to batch, but the results for each batch were consistent and reproducible when expressed as percentages of control values for the different cell suspensions tested ( Fig. 1A and B) . Therefore, dose-response curves were calculated for the effects of each batch on PHA-and PPD-stimulated cultures. For PHA stimulation, the statistically most probable curve was fitted by a second- (Table II) . A small decrease in the effects of CEP-Si was observed for pure T cells as compared with unseparated mononuclear cells when low concentrations of CEP-Si were used; however, this observation probably reflects a reduction in the effects of CEP-Si in poorly stimulated cultures rather than mediation of the effects by monocytes.
Immunosuppressive Products of Streptococcus intermedius
The effects of CEP-Si on protein synthesis as assessed by [3HJleucine uptake were highly dependent upon the conditions of culture, being much weaker in serum-free mononuclear cell cultures than in those containing serum, for both PPD and PHA stimulation (Table III) . In PHA-stimulated cultures that contained serum, the suppression was greater when the cells were harvested after 3 (Fig. 2A) . The effect was progressively reduced when the CEP-Si was added at longer intervals after the initiation of culture, in proportion to the length of its presence in the culture, in both PHA-and PPD-stimulated cultures ( Fig. 2A and B) . No suppression was seen with small doses of CEP-Si added only 24 h before the cultures were harvested.
[3H]Thymidine uptake values at different times in PHA-stimulated cultures treated with CEP-Si parallelled those in controls for a certain time, after which they increased less rapidly than controls and, after reaching a maximum level, dropped abruptly (Fig. 3) . The abrupt drop occurred sooner when higher doses of CEP-Si were used. In general, the minimum values in treated cultures coincided with the time of maximum stimulation in controls. Interestingly, the values in the treated cultures began to increase after reaching the minimum level (i.e., after the controls reached maximum stimulation levels) (Fig. 3 IA and IB) . This increase occurred sooner, however, when higher doses of CEP-Si were added. Moreover, as shown in Fig. 3 IIA and B, in two experiments the increase and abrupt drop occurred even sooner when the cultures were supplemented daily with CEP-Si than when they were supplemented only at the beginning of the culture.
Evidence for noncytotoxicity of CEP-Si. spontaneous proliferation, proportional to the dose used. were treated with CEP-Si, formation of hemolytic plaques against SRBC in vitro was strongly inhibited, in proportion to the dose of CEP-Si. When these cells were treated with CEP-Si and then washed twice, they induced an increase in hemolytic plaques when added to untreated fresh autologous normal cells stimulated by MLC alone, whereas they induced a slight but consistent decrease when added to the same fresh autologous normal cells stimulated by both MLC and SRBC. This decrease was proportional to the number of CEP-Si-treated cells added (Fig. 4) . Cells treated with PPD and subsequently washed either slightly enhanced or had no effect on hemolytic plaque formation by fresh cells stimulated by MLC Mice receiving doses of CEP-Si up to 5,000 U of PPD biological activity showed no weight loss. When test animals were injected weekly with 5,000 U of PPD biological activity for 5 wk, no signs of toxicity were seen, and their primary responses to SRBC 3 mo after the treatment were equivalent to those ofcontrols.
Preliminary fractionation of CEP-Si. The suppressor effect of CEP-Si was detected only in two fractions, out of nine, obtained by isoelectric focusing. One of the fractions was able to suppress PPD-or PHAstimulated cultures, and the other was able to suppress only PPD-stimulated cultures. The first and the latter of these fractions contained substances with isoelectric point at pH 4.5-5 and 3.5-4, respectively. The suppressor effect on PPD-stimulated cultures was at least five times higher in the latter fraction than in the first. Both fractions were noncytotoxic, and, like for CEP-Si, the suppressor effect in vitro was observed more easily if the fractions were added to the cultures before the stimulant. As the suppressor effects of CEP-Si in vivo correlated excellently with the in vitro suppressor effects on PPD-stimulated cultures, the fraction able to suppress the PPD response was tested in vivo. Like for CEP-Si, this fraction was able to suppress the response to SRBC of C57BL/6 mice only if administered before the immunogen, i.e., strong suppression was observed at days -6, -4, and -2, but no inhibition of the response was observed at days 0, +2, or +4. The effect of this fraction was also proportional to the amount injected into the animals. Preliminary results indicate that the fraction less active on suppressing the PPD response was active in vivo as well but roughly at least four times less active than the other fraction.
DISCUSSION
The possibility that the suppressor effects of CEP-Si were a result of contamination with constituents of the culture medium can be excluded on the basis of the finding that control preparations (Methods) did not cause suppression in PHA-or PPD-stimulated cultures, even at dilutions of 1/20.
As for other substances extracted from or produced by bacteria (11) (12) (13) (14) (15) (16) (17) (18) which are not toxins, it was found that CEP-Si was not cytotoxic, as shown by (a) the viability and proliferative ability of cells incubated with large doses and then washed, (b) its lack of inhibition of normal migration of PMN effects of some bacterial substances -e.g., lipoteichoic acid (15)-may represent competition between these substances and antigens as a result of blocking of the relevant receptors (11) . These studies clearly exclude this possibility for the products secreted by S. intermedius, as they can strongly suppress the immune response to a variety of antigens, as well as cell proliferation in response to several mitogens. It is highly unlikely that one or more substances secreted by a single bacterial species would share antigenic determinants with such a wide variety of stimulants. In addition, although CEP-Si progressively loses its suppressor activity when added to the cultures at later times, its effects are the same whether it is added at the beginning of the culture or 8 h after the addition of PHA. In this respect, it is well known that PHA requires only a short time of contact with lymphocytes to trigger cell proliferation, because the mitogenic effect is equally strong whether the cells are exposed to PHA throughout the culture period or only for a short incubation period after which they are washed and reincubated in medium without PHA.
A major concern in studies of [3H]thymidine uptake is the possibility that a high concentration of unlabeled thymidine in the culture could cause a reduction in uptake that would be falsely interpreted as inhibition (32) (33) (34) . In this study, the possibility of this artifact was ruled out by several observations. First, morphological controls were carried out, and the results correlated roughly with the results for [3H]thymidine uptake. Second, when several doses of CEP-Si, which caused strong suppressor effects on thymidine uptake by PHA-or PPD-stimulated cells when added at the beginning of the cultures, were added immediately before the cultures were pulsed with labeled thymidine (24 h began to increase again, although the test substance was still present in the cultures. Moreover, an excellent correlation was also observed between the effects of CEP-Si in vitro and in vivo. As in PHA-or PPDstimulated cultures, the effects were time dependent in test animals, the effect being stronger when the CEP-Si was injected at longer times before SRBC (although at very early injection times, e.g., 15 d before immunization, the effect was negated, probably because the material was degraded in vivo).
Perhaps the most important observation in this respect was the excellent correlation between the suppressor effects of CEP-Si in PPD-stimulated cultures and the effects of various amounts (measured in PPD biological units) injected on day -2. However, it should be emphasized that for PPD stimulation in vitro, we purposely selected donors with exquisite sensitivity to PPD, and thus it is questionable whether such a high correlation would be found for mononuclear cell cultures derived from nonresponsive or slightly sensitive individuals. These correlations between in vitro and in vivo effects of CEP-Si clearly exclude a similarity between this substance(s) and the bacterial extracts of group A streptococci (12) (13) (14) , which have proven to be totally ineffective in vitro, although both substances are strong noncytotoxic immunosuppressors and are more effective when administered before antigen challenge.
In view of the observations that CEP-Si is noncytotoxic and has suppressor effects which are potentiated with increasing times ofcontact in vitro and in vivo (with the exception of much longer periods in vivo), it is tempting to speculate, in light of current knowledge of immunosuppression (35) (40) . Such a reaction could also explain the lack of decrease in [3H] thymidine uptake in cultures of PHA-or PPD-stimulated fresh cells supplemented with CEP-Si-treated cells, because uptake by the proliferating cells would mask any inhibition of the mitogen or antigen response.
It is surprising, however, that human cells treated with CEP-Si, unlike ConA-induced suppressor cells, which suppress formation of hemolytic plaques against SRBC by both mouse (41) (42) (43) (44) (45) and human (46) cells, increased rather than reduced the number of human mononuclear cells forming hemolytic plaques when stimulated by MLC but not by SRBC. A clear-cut but small inhibition of plaque formation was observed, however, when fresh normal cells stimulated by both MLC and SRBC were incubated with autologous cells pretreated with CEP-Si and SRBC. One attractive explanation for these latter observations might be the possibility that the observed suppression was specifically induced to the stimulant, inasmuch as cells treated with PPD and CEP-Si, unlike those treated with CEP-Si and SRBC, failed to inhibit hemolytic plaque formation by fresh cells stimulated by MLC and SRBC. This hypothesis would also explain why the suppressor effects of CEP-Si are greater in MLC-than PPD-stimulated cultures and greater in the latter than in PHA-stimulated cultures. These observations, which suggest that CEP-Si can induce the generation of suppressor cells, indicate a lack of similarity between CEP-Si and immunosuppressive enzymes secreted by other bacteria (16) (17) (18) . Indeed, the enzymatic suppressor effect is assumed to be a result of the destruction of essential cellular nutrients, such as amino acids (11) , and therefore their effects are more likely a result of inhibition of helper and effector cells. Consequently, their effects would not be expected to show selectivity for some stimulants or to produce faster recovery of proliferation when added to cultures daily rather than only at the beginning ofthe cultures, as found for CEP-Si.
In conclusion, we report that S. intermedius is able to secrete a noncytotoxic substance(s), unrelated to other bacterial substances described previously, which strongly suppresses the immune responses (most likely by inducing specific suppressor cells) to a variety of antigens and mitogens in vitro, the action of which correlates well with its effects in vivo. We realize that fractionation of CEP-Si is an important step in identifying the active substance(s), and purification of the suppressor activity in CEP-Si is now in progress. Upon preliminary fractionation of CEP-Si it was observed that the suppressor effects were found in two fractions. No enhancing effects were observed whatsoever, and therefore it is unlikely that the effects observed with crude preparations were a result of the combined effects of opposite (i.e., helper and suppressor) signals.
